Tines 3B vs Needle 2.0
Side-by-side comparison of features, pros & cons, pricing, and community votes (2026).
🏆 Needle 2.0 leads with 609 upvotes

The secure environment for agents, apps, and automations
Tines 3B is a secure, code-first automation platform designed for organizations that prioritize security and compliance. It provides a unified environment where agents, applications, and automations can operate seamlessly, with a focus on safeguarding credentials and sensitive data. Built with AI integration and offering a cloud-based, isolated runtime, Tines 3B enables teams to develop and deploy workflows from anywhere without sacrificing security or control. Its auditable and monitored infrastructure ensures transparency and accountability, making it ideal for security teams, developers, and enterprise operations seeking reliable automation solutions. The Explore Edition, granting access to three live workflows with unlimited users, spaces, and connectors, makes it accessible for teams to experiment and scale their automation efforts efficiently.
Pros
- Highly secure environment with isolated code execution and credential protection
- AI-native and code-first approach allows for flexible and advanced automation development
- Fully auditable and monitored platform enhances transparency and compliance
- Accessible from anywhere, supporting remote collaboration
- Generous free tier with multiple workflows, users, and connectors
Cons
- May have a learning curve for users unfamiliar with code-based automation
- Limited features in the free Explore Edition compared to full enterprise plans
- Potentially smaller community and integrations compared to more established platforms
Best for
- • Automating security incident response and threat detection workflows
- • Integrating AI to enhance alert triage and decision-making
- • Building secure, scalable automation for enterprise IT operations
- • Managing credentials and secrets securely within automated processes
Pricing: Likely operates on a subscription model with a free tier (Explore Edition) offering limited workflows and unlimited users, with paid plans providing additional features, workflows, and enterprise support.

Vibe-automate workflows and earn passive income
Needle 2.0 is an innovative AI-powered automation platform designed for both no-code enthusiasts and experienced AI builders. Its core feature allows users to specify workflows they want to automate simply by describing their needs, with the system's builder agent handling the entire process—building, testing, and deploying workflows in real-time. This hands-free approach drastically reduces the time and technical skill required to implement complex automation, making it accessible to a broad audience. Additionally, Needle 2.0 introduces a unique monetization aspect, enabling users to submit their custom workflows and earn passive income, fostering a community of AI creators and entrepreneurs. With a strong presence on Product Hunt and thousands of votes, Needle 2.0 clearly resonates with users seeking effortless automation and new income streams in the AI era.
Pros
- User-friendly, no-code automation builder that simplifies complex workflows
- Real-time building, testing, and deployment for quick results
- Unique passive income opportunity for AI builders
- Supports a wide range of automation use cases across industries
- Active community with high engagement and feedback
Cons
- Potential limitations in customization for highly complex workflows
- Uncertain pricing details—likely subscription-based with premium tiers
- May require some learning curve for complete beginners
Best for
- • Automating marketing campaigns and lead nurturing
- • Streamlining customer support workflows with AI chatbots
- • Data extraction and integration tasks from various sources
- • Content generation and social media automation
Pricing: Likely employs a freemium model with free access to basic features and paid plans starting around $20-$50/month for advanced automation and monetization options. Exact details are not publicly confirmed.